N@N

Market Maker Surveillance Report. SIGM, FTK, RPRX, RXII, OHRP, RCAR, Losing Stocks With Lowest Price Friction For Wednesday, D

^{Published on 2016-12-07 18:47:06 - WOPRAI}
 

December 7, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 5227 companies with "abnormal" market making, 4452 companies with positive Friction Factors and 2104 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Wednesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Sigma Designs, Inc. (NASDAQ:SIGM), Flotek Industries Inc. (NYSE:FTK), Repros Therapeutics Inc. (NASDAQ:RPRX), Galena Biopharma Inc. (NASDAQ:RXII), Ohr Pharmaceutical Inc. (NASDAQ:OHRP), RenovaCare Inc. (OTC:RCAR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  SIGM    $-2.150   -0.28%    2,284,146    30.82%    2,505,023    33.80%    -220,877     -1,027  
  FTK     $-2.010   -0.15%    2,743,153    35.61%    2,836,726    36.82%    -93,573      -466    
  RPRX    $-0.290   -0.15%    202,572      34.38%    268,619      45.59%    -66,047      -2,277  
  RXII    $-0.300   -0.15%    149,928      40.31%    152,942      41.12%    -3,014       -100    
  OHRP    $-0.400   -0.15%    30,292       42.07%    35,660       49.52%    -5,368       -134    
  RCAR    $-0.560   -0.20%    201,012      38.11%    263,386      49.94%    -62,374      -1,114  

For example, the chart above shows SIGM with a dollar loss Wednesday of $-2.15000 and a Friction Factor of -1,027 shares. That means that it only took 1,027 more shares of selling than buying to move SIGM lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Sigma Designs, Inc. (NASDAQ:SIGM) - Sigma Designs, Inc., an integrated semiconductor solutions provider, provides intelligent media platforms for use in the home entertainment and home control markets. The company s media processor product line includes a range of platforms that are based on integrated chips, embedded software, and hardware reference designs. Its media connectivity product line comprises wired home networking controller chipsets that provide connectivity solutions between various home entertainment products and incoming video streams. The company s Internet of things devices consist of wireless Z-Wave chipsets and modules that enable home security, and environmental and energy control and monitoring in new and existing homes. It also offers legacy products; and software development kits, engineering support services for hardware and software, engineering development for customization of chipsets, and other accessories. The company markets and sells its products through direct sales force, manufacturer representatives, distributors, and resellers to end-product manufacturers, original equipment manufacturers, and original design manufacturers in Asia, North America, Europe, and internationally. Sigma Designs, Inc. has a collaboration agreement with Telechips, Inc. to develop and market advanced SoC solutions for the ultra-high-definition IP streaming set-top boxes. The company was founded in 1982 and is headquartered in Fremont, California..

Flotek Industries Inc. (NYSE:FTK) - Flotek Industries, Inc. develops and supplies oilfield products, services, and equipment to the oil, gas, and mining industries in the United States and internationally. The company s Energy Chemistry Technologies segment designs, develops, manufactures, packages, and markets chemistries under the Complex nano-Fluid brand for use in oil and gas well drilling, cementing, completion, stimulation, and production activities, as well as for use in enhanced and improved oil recovery markets. This segment also constructs and manages automated material handling facilities; and manages loading facilities and blending operations for oilfield services companies. Its Consumer and Industrial Chemistry Technologies segment designs, develops, processes, manufactures, and sells citrus oils for food and beverage companies, fragrance companies, and companies providing household and industrial cleaning products, as well as for use in the oil and gas industry. The company s Drilling Technologies segment inspects, manufactures, sells, markets, and rents down-hole drilling equipment that are used in energy, mining, and industrial drilling activities through direct and agent-based sales. This segment also rents stabilizers, drill collars, reamers, wipers, jars, shock subs, wireless survey, measurement while drilling tools, Stemulator tools, and mud-motors; and sells mining equipment, cementing accessories, and drilling motor components. Its Production Technologies segment assembles and markets the Petrovalve product line of rod pump components, hydraulic pumping units, electric submersible pumps, gas separators, valves, and services that support natural gas and oil production activities. The company also provides reservoir engineering and modeling services for various hydrocarbon applications. It also serves pressure pumping service, supply chain management, cosmetic, and national and state-owned oil companies. The company is headquartered in Houston, Texas..

Repros Therapeutics Inc. (NASDAQ:RPRX) - Repros Therapeutics Inc., a biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders for male and female in the United States. Its product portfolio includes enclomiphene, an oral therapy, which is in Phase III clinical trials for the treatment of low testosterone levels due to secondary hypogonadism; and Proellex that is in Phase IIB clinical trials for the treatment of symptoms associated with uterine fibroids, as well as in Phase II clinical trial for the treatment of endometriosis. The company has a license agreement with the National Institutes of Health to develop and commercialize Proellex. Repros Therapeutics Inc. was founded in 1987 and is based in The Woodlands, Texas..

Galena Biopharma Inc. (NASDAQ:RXII) - RXi Pharmaceuticals Corporation, a clinical-stage RNAi company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents. Its clinical development programs include RXI-109, a self-delivering RNAi compound, which is in Phase IIa clinical trial that is used to prevent or reduce dermal scarring following surgery or trauma, as well as for the management of hypertrophic scars and keloids; and a Phase I/II clinical trial in retinal scarring. It is also developing RXI-109 for the treatment of an ophthalmic indication, focusing on retinal and corneal scarring; and Samcyprone, a formulation of diphenylcyclopropenone, which is in Phase II clinical trial for the treatment of various disorders, such as warts, alopecia areata, non-malignant skin tumors, and cutaneous metastases of melanoma. In addition, the company is developing dermal scarring and wart programs with its sd-rxRNA technology. The company was incorporated in 2011 and is headquartered in Marlborough, Massachusetts..

Ohr Pharmaceutical Inc. (NASDAQ:OHRP) - OHR Pharmaceutical, Inc., a pharmaceutical company, focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its lead clinical program is OHR-102 eye drops, a novel therapeutic product, which could provide a non-invasive therapy to enhance vision outcomes. The company is evaluating OHR-102 eye drops, which completed Phase II clinical trials for the treatment of retinal diseases, including wet-AMD, retinal vein occlusion, and proliferative diabetic retinopathy. Its preclinical pipeline of sustained release programs include sustained release formulations of small molecule and protein therapeutics for the treatment of ocular diseases, such as steroid induced glaucoma, allergies, and retinal disease. OHR Pharmaceutical, Inc. is headquartered in New York, New York..

RenovaCare Inc. (OTC:RCAR) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net